Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and characterization of a cell donor registry for virus-specific T cell manufacture in a blood bank.

HLA - 1 Mar 2024

Rudilla Francesc, Carrasco-Benso María Paz, Pasamar Helena, López-Montañés María, Andrés-Rozas María, Tomás-Marín Maria, Company Desirée, Moya Cristina, Larrea Luis, Guerreiro Manuel, Barba Pere, Arbona Cristina, Querol Sergio

Abstract excerpt

Adoptive cell therapy using virus-specific T cells (VST) is a strategy for treating common opportunistic viral infections after transplantation, particularly when these infections do not resolve through antiviral drug therapy. The availability of third-party healthy donors allows for the immediate use of cells for allogeneic therapy in cases where patients lack an appropriate donor. Here, we present the creation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Donors
Share to Cytomegalovirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytomegalovirus Infections

Share to Epstein-Barr Virus Infections

Share to Herpesvirus 4, Human

Share to Histocompatibility Antigens Class II

Share to HLA-A Antigens

Share to T-Lymphocytes

Source

Identifiers

PMID: 38450972
DOI: 10.1111/tan.15419

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and characterization of a cell donor registry for virus-specific T cell manufacture in a blood bank.PMID 38450972Read ↗

Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registrySemantic proximity Read ↗

Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant ProgramSemantic proximity Read ↗

Immunogenetics in stem cell donor registry work: The DKMS example (Part 2).Semantic proximity Read ↗

BK Virus-Specific T Cell Response Associated with HLA Genotypes, RhD Status, and CMV or EBV Serostatus in Healthy Donors for Optimized Cell Therapy.Semantic proximity Read ↗

Immunogenetics in stem cell donor registry work: The DKMS example (Part 1)Semantic proximity Read ↗

Unrelated hematopoietic stem cell donor registries: present reality and future prospectsSemantic proximity Read ↗

A study of selected hematopoietic stem cell donors provided by an intermediate size registry.Semantic proximity Read ↗

SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPYSemantic proximity Read ↗

Universal cell donor lines: A review of the current researchSemantic proximity Read ↗

Allogeneic hematopoietic stem cell transplant recipients in Spain: Human leukocyte antigen characteristics and diversity by high-resolution analysis.Semantic proximity Read ↗

Creating an HLA-homozygous iPS cell bank for the Brazilian population: Challenges and opportunities.Semantic proximity Read ↗

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.